geron corporationpure price action , i see this asset making the last push to the down before going higher
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.32 USD
−184.13 M USD
237.00 K USD
564.66 M
About Geron Corporation
Sector
Industry
CEO
John A. Scarlett
Website
Headquarters
Foster City
Founded
1990
FIGI
BBG000GX1891
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
Long GERN @4.43 Oversold in a strong recent uptrend. Will hold each lot until it is both overbought AND profitable. No stops for me. Had a dizzying 40% drawdown back in September '23 and held 14 lots at the bottom of that.
In the end, though, all 14 (and the next 13) turned a profit. The indicator and exit str
GERN - PDUFA Data Release on 16/06/2024Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blo
GERON Corporation Bullish momentum
Title:
GERON Corporation: Bullish Momentum
Overview:
🌟 Hello Traders,
GERON Corporation is currently exhibiting bullish momentum, indicating potential opportunities for traders in the market.
NASDAQ:GERN
Key Points:
- GERON Corporation is experiencing strong bullish momentum, with
Geron's Imetelstat Receives FDA Advisors' BackingGeron Corporation's ( NASDAQ:GERN ) blood disorder drug, Imetelstat, has received a crucial vote of confidence from advisers to the U.S. Food and Drug Administration (FDA). Despite initial concerns raised by the agency's staff regarding data clarity and safety issues, the advisory panel overwhelming
GERON Stock Chart Fibonacci Analysis 022724Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 2.2/61.80%
Chart time frame : B
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress : B
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) Hit the bottom
D) Hit the top
GERN - long - Catalyst playGeron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a
gern buy idea with stop shown in the graphgern buy idea with stop shown in the graph
we must keep the stop as shown in the graph
BUY GERON CORP. (GERN)Shares of Geron have been on the retail trader’s radar following a series of news and industry catalysts. The late-stage biopharmaceutical company specializes in developing treatments for hematologic malignancies. At the beginning of the year, the company announced positive top-line results from its
GERN: Daily VCPSetup: Rocketbase
VCP: 5W 39/6 4T
RS: 98
The posted chart contains a VCP (volatility contraction pattern). The first label "W" stands for weekly and shows the duration of the entire consolidation. In the middle label, the percentage of contractions is indicated (for example, "15/4"), with 15 repre
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GERN is 3.34 USD — it has decreased by −4.30% in the past 24 hours. Watch Geron Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Geron Corporation stocks are traded under the ticker GERN.
GERN stock has fallen by −13.70% compared to the previous week, the month change is a −16.08% fall, over the last year Geron Corporation has showed a 48.44% increase.
We've gathered analysts' opinions on Geron Corporation future price: according to them, GERN price has a max estimate of 10.00 USD and a min estimate of 5.50 USD. Watch GERN chart and read a more detailed Geron Corporation stock forecast: see what analysts think of Geron Corporation and suggest that you do with its stocks.
GERN reached its all-time high on Mar 3, 2000 with the price of 71.69 USD, and its all-time low was 0.75 USD and was reached on Mar 16, 2020. View more price dynamics on GERN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GERN stock is 2.13% volatile and has beta coefficient of 1.16. Track Geron Corporation stock price on the chart and check out the list of the most volatile stocks — is Geron Corporation there?
Today Geron Corporation has the market capitalization of 2.02 B, it has decreased by −1.26% over the last week.
Yes, you can track Geron Corporation financials in yearly and quarterly reports right on TradingView.
Geron Corporation is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
GERN earnings for the last quarter are −0.04 USD per share, whereas the estimation was −0.08 USD resulting in a 52.34% surprise. The estimated earnings for the next quarter are −0.03 USD per share. See more details about Geron Corporation earnings.
Geron Corporation revenue for the last quarter amounts to 28.27 M USD, despite the estimated figure of 18.97 M USD. In the next quarter, revenue is expected to reach 61.93 M USD.
GERN net income for the last quarter is −26.45 M USD, while the quarter before that showed −67.38 M USD of net income which accounts for 60.75% change. Track more Geron Corporation financial stats to get the full picture.
No, GERN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 141.00 employees. See our rating of the largest employees — is Geron Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Geron Corporation EBITDA is −206.82 M USD, and current EBITDA margin is −81.40 K%. See more stats in Geron Corporation financial statements.
Like other stocks, GERN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Geron Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Geron Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Geron Corporation stock shows the neutral signal. See more of Geron Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.